Evidence map›Paper›PMID 39687089›Full record

ArticleHeliyon2024

Simultaneous care provision to patients with small cell lung cancer in Lazio region: Practical recommendations of a multidisciplinary group.

Sabrina Mariotti, Gabriele Minuti, Lorenza Landi, Emilio Bria, Giorgia Carlucci, Mariantonietta Di Salvatore, Raffaele Giusti, Aurelia Iurato, Sara Ramella, Maria Adelaide Ricciotti and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sabrina MariottiUOSD Oncologia Medica, Policlinico Tor Vergata, Roma, Italy.
Gabriele MinutiUOSD Sperimentazioni cliniche: Fase 1 e Medicina di Precisione, Istituto Nazionale Tumori "Regina Elena", Roma, Italy.
Lorenza LandiUOSD Sperimentazioni cliniche: Fase 1 e Medicina di Precisione, Istituto Nazionale Tumori "Regina Elena", Roma, Italy.
Emilio BriaUOSD Oncologia Toraco-Polmonare, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
Giorgia CarlucciOPT S.p.A. - Soluzioni per il Mondo Healthcare, Milan, Italy.
Mariantonietta Di SalvatoreUOSD Oncologia Toraco-Polmonare, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
Raffaele GiustiUOC Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Roma, Italy.
Aurelia IuratoUOC Radioterapia Oncologica, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.
Sara RamellaUOC Radioterapia Oncologica, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.
Maria Adelaide RicciottiUOC Cure Palliative, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
Gian Paolo SpinelliUOC Oncologia Territoriale, CdS Aprilia - ASL Latina, Università Sapienza, Roma, Italy.
Marco TineriCure palliative, ICOT Istituto Marco Pasquali, Latina, Roma, Italy.
Francesco ScarcellaUOSD Hospice e Cure Simultanee, ASL Rieti, Rieti, Italy.
Mario Rosario D'andreaUOSD Oncologia ASL Roma 4, Hospice Carlo Chenis, Civitavecchia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-Cell Lung Cancer (SCLC) accounts for 15 % of all lung cancer cases. Due to comorbidities and its aggressive behaviour, patients are highly symptomatic even at a non-metastatic stage. Standardizing the care pathway and introducing a simultaneous care approach could address the unmet needs of this disease. However, there is no uniformity in the involvement of palliative care physicians and in the simultaneous use of palliative care and cancer therapies. In this context, 13 experts from Lazio region undertook a process to deepen their understanding of the regional provision of simultaneous care to patients with SCLC by structuring and carrying out a survey. The survey covered 35-52 % of SCLC cases in the region, confirming heterogeneous results in both management and therapeutic approach, particularly in the area of simultaneous care. The working group met to define practical recommendations with the aim of standardizing the management of this disease.

Indexed as

Diagnostic and therapeutic care pathwaysMultidisciplinary teamSimultaneous careSmall-cell lung cancer

Identifiers

PMID39687089
PMCPMC11648118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.